Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Giordano Christopher Thomas | CEO | Jul 13 '26 | Option Exercise | 5.88 | 8,719 | 51,267 | 11,324 | Jul 14 07:29 PM |
| Rich Stuart | Chief Medical Officer | Dec 09 '25 | Buy | 10.22 | 2,500 | 25,542 | 5,266 | Dec 10 06:48 PM |
| Rich Stuart | Chief Medical Officer | Dec 08 '25 | Buy | 10.10 | 2,500 | 25,250 | 5,000 | Dec 10 06:48 PM |
| Rich Stuart | Chief Medical Officer | Dec 04 '25 | Buy | 9.20 | 2,500 | 22,998 | 2,500 | Dec 05 05:46 PM |
| Rich Stuart | Chief Medical Officer | Dec 03 '25 | Buy | 9.08 | 1,500 | 13,618 | 2,766 | Dec 05 05:46 PM |
| Rich Stuart | Chief Medical Officer | Dec 02 '25 | Buy | 9.01 | 1,000 | 9,006 | 1,266 | Dec 05 05:46 PM |
| Giordano Christopher Thomas | CEO | Nov 18 '25 | Buy | 7.75 | 1,612 | 12,500 | 1,612 | Nov 20 06:38 PM |
| Giordano Christopher Thomas | CEO | Nov 20 '25 | Buy | 7.59 | 538 | 4,083 | 2,605 | Nov 20 06:38 PM |
| Giordano Christopher Thomas | CEO | Nov 19 '25 | Buy | 7.51 | 455 | 3,417 | 2,067 | Nov 20 06:38 PM |
| MCGAULEY THOMAS | Interim CFO | Nov 17 '25 | Buy | 7.25 | 6,000 | 43,490 | 5,000 | Nov 19 07:01 PM |
| MCGAULEY THOMAS | Interim CFO | Nov 17 '25 | Buy | 7.34 | 2,000 | 14,674 | 2,000 | Nov 19 07:01 PM |
| Almenoff June Sherie | Director | Nov 18 '25 | Buy | 7.52 | 1,900 | 14,280 | 1,993 | Nov 19 06:43 PM |
| Almenoff June Sherie | Director | Nov 17 '25 | Buy | 7.15 | 93 | 665 | 93 | Nov 19 06:43 PM |